{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:34:50Z","timestamp":1787830490683,"version":"build-2784847793"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T00:00:00Z","timestamp":1645142400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadinternational.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD International"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jdin.2022.02.006","type":"journal-article","created":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T23:41:05Z","timestamp":1645486865000},"page":"67-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"special_numbering":"C","title":["Alopecia in patients with COVID-19: A\u00a0systematic review and meta-analysis"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0402-3926","authenticated-orcid":false,"given":"Betty","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Tosti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jdin.2022.02.006_bib1","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1111\/jdv.16545","article-title":"COVID-19 and dermatology: a comprehensive guide for dermatologists","volume":"34","author":"Fahmy","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.jdin.2022.02.006_bib2","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13549","article-title":"Cutaneous signs in COVID-19 patients: a review","volume":"33","author":"Wollina","year":"2020","journal-title":"Dermatol Ther"},{"issue":"6","key":"10.1016\/j.jdin.2022.02.006_bib3","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13986","article-title":"Cutaneous manifestations and considerations in COVID-19 pandemic: a systematic review","volume":"33","author":"Seirafianpour","year":"2020","journal-title":"Dermatol Ther"},{"issue":"4","key":"10.1016\/j.jdin.2022.02.006_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15004","article-title":"Androgenetic alopecia and COVID-19: a review of the hypothetical role of androgens","volume":"34","author":"Moravvej","year":"2021","journal-title":"Dermatol Ther"},{"issue":"1","key":"10.1016\/j.jdin.2022.02.006_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12020-020-02536-6","article-title":"Sex differences in COVID-19: the role of androgens in disease severity and progression","volume":"71","author":"Mohamed","year":"2021","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.jdin.2022.02.006_bib6","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.dsx.2020.10.014","article-title":"The role of androgens in COVID-19","volume":"14","author":"Moradi","year":"2020","journal-title":"Diabetes Metab Syndr"},{"issue":"4","key":"10.1016\/j.jdin.2022.02.006_bib7","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.jaad.2021.07.021","article-title":"Time of onset and duration of post-COVID-19 acute telogen effluvium","volume":"85","author":"Abrantes","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.jdin.2022.02.006_bib8","doi-asserted-by":"crossref","first-page":"e411","DOI":"10.1111\/jdv.17170","article-title":"Rapidly progressive alopecia areata totalis in a COVID-19 patient, unresponsive to tofacitinib","volume":"35","author":"Berbert Ferreira","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.jdin.2022.02.006_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14685","article-title":"Alopecia areata in a COVID-19 patient: a case report","volume":"34","author":"Capalbo","year":"2021","journal-title":"Dermatol Ther"},{"issue":"1","key":"10.1016\/j.jdin.2022.02.006_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2020-000813","article-title":"Clinical characteristics and outcomes of adult patients admitted with COVID-19 in East London: a retrospective cohort analysis","volume":"8","author":"Cheng","year":"2021","journal-title":"BMJ Open Respir Res"},{"issue":"7","key":"10.1016\/j.jdin.2022.02.006_bib11","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/exd.14352","article-title":"Pathobiology questions raised by telogen effluvium and trichodynia in COVID-19 patients","volume":"30","author":"Di Landro","year":"2021","journal-title":"Exp Dermatol"},{"issue":"1","key":"10.1016\/j.jdin.2022.02.006_bib12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/ijd.15317","article-title":"COVID-19: association with rapidly progressive forms of alopecia areata","volume":"60","author":"FIvenson","year":"2021","journal-title":"Int J Dermatol"},{"issue":"11","key":"10.1016\/j.jdin.2022.02.006_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241540","article-title":"The impact of individual lifestyle and status on the acquisition of COVID-19: a case-control study","volume":"15","author":"Gao","year":"2020","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.jdin.2022.02.006_bib14","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/jocd.13443","article-title":"A preliminary observation: male pattern hair loss among hospitalized COVID-19 patients in Spain\u2014a potential clue to the role of androgens in COVID-19 severity","volume":"19","author":"Goren","year":"2020","journal-title":"J Cosmet Dermatol"},{"issue":"2","key":"10.1016\/j.jdin.2022.02.006_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14820","article-title":"Different hair loss patterns in two pediatric patients with COVID-19-associated multisystem inflammatory syndrome in children","volume":"34","author":"Hayran","year":"2021","journal-title":"Dermatol Ther"},{"issue":"5","key":"10.1016\/j.jdin.2022.02.006_bib16","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.1016\/j.jaad.2020.07.062","article-title":"Male balding is a major risk factor for severe COVID-19","volume":"83","author":"Lee","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdin.2022.02.006_bib17","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2147\/CCID.S307982","article-title":"A case of acute telogen effluvium after SARS-CoV-2 infection","volume":"14","author":"Lv","year":"2021","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.jdin.2022.02.006_bib18","first-page":"79","article-title":"Acral rash in a child with COVID-19","volume":"30","author":"Mazzotta","year":"2020","journal-title":"Eur J Pediatr Dermatol"},{"issue":"1","key":"10.1016\/j.jdin.2022.02.006_bib19","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/ijd.15313","article-title":"Telogen effluvium: a sequela of COVID-19","volume":"60","author":"Mieczkowska","year":"2021","journal-title":"Int J Dermatol"},{"issue":"11","key":"10.1016\/j.jdin.2022.02.006_bib20","doi-asserted-by":"crossref","first-page":"ofaa507","DOI":"10.1093\/ofid\/ofaa507","article-title":"Prolonged and late-onset symptoms of coronavirus disease 2019","volume":"7","author":"Miyazato","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"10.1016\/j.jdin.2022.02.006_bib21","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1111\/jdv.17045","article-title":"SARS-CoV-2-induced telogen effluvium: a multicentric study","volume":"35","author":"Moreno-Arrones","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"12","key":"10.1016\/j.jdin.2022.02.006_bib22","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/exd.14220","article-title":"Alopecia and grey hair are associated with COVID-19 severity","volume":"29","author":"Muller Ramos","year":"2020","journal-title":"Exp Dermatol"},{"issue":"2","key":"10.1016\/j.jdin.2022.02.006_bib23","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14761","article-title":"Telogen effluvium associated with COVID-19 infection","volume":"34","author":"Olds","year":"2021","journal-title":"Dermatol Ther"},{"issue":"suppl 1","key":"10.1016\/j.jdin.2022.02.006_bib24","first-page":"A5","article-title":"Clinical characteristics, mortality and short term follow up of patients admitted with COVID-19 in a North East London NHS Trust: a retrospective analysis","volume":"76","author":"Patel","year":"2021","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.jdin.2022.02.006_bib25","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14764","article-title":"Pressure-induced alopecia due to proning in COVID-19","volume":"34","author":"Perry","year":"2021","journal-title":"Dermatol Ther"},{"issue":"2","key":"10.1016\/j.jdin.2022.02.006_bib26","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s40199-020-00369-2","article-title":"Comparing outcomes of hospitalized patients with moderate and severe COVID-19 following treatment with hydroxychloroquine plus atazanavir\/ritonavir","volume":"28","author":"Rahmani","year":"2020","journal-title":"Daru"},{"issue":"2","key":"10.1016\/j.jdin.2022.02.006_bib27","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s13555-021-00498-9","article-title":"Italian survey for the evaluation of the effects of coronavirus disease 2019 (COVID-19) pandemic on alopecia areata recurrence","volume":"11","author":"Rinaldi","year":"2021","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"1","key":"10.1016\/j.jdin.2022.02.006_bib28","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14547","article-title":"Telogen effluvium related to post severe SARS-CoV-2 infection: clinical aspects and our management experience","volume":"34","author":"Rizzetto","year":"2021","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jdin.2022.02.006_bib29","first-page":"1","article-title":"Telogen effluvium after SARS-CoV-2 infection: a series of cases and possible pathogenetic mechanisms","volume":"21","author":"Rossi","year":"2021","journal-title":"Skin Appendage Disord"},{"issue":"7","key":"10.1016\/j.jdin.2022.02.006_bib30","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1111\/jocd.14080","article-title":"New onset of alopecia areata in a patient with SARS-CoV-2 infection: possible pathogenetic correlations?","volume":"20","author":"Rossi","year":"2021","journal-title":"J Cosmet Dermatol"},{"issue":"3","key":"10.1016\/j.jdin.2022.02.006_bib31","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jaad.2021.05.020","article-title":"Mild-to-moderate COVID-19 is not associated with worsening of alopecia areata: a retrospective analysis of 32 patients","volume":"85","author":"Rudnicka","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jdin.2022.02.006_bib32","first-page":"700","article-title":"Telogen effluvium: long term Covid-19 symptom","volume":"30","author":"Saeed","year":"2020","journal-title":"J Pak Assoc Dermatol"},{"issue":"1","key":"10.1016\/j.jdin.2022.02.006_bib33","first-page":"37","article-title":"Alopecia and severity of COVID-19: a cross-sectional study in Peru","volume":"29","author":"Salazar Arenas","year":"2021","journal-title":"Infez Med"},{"issue":"6","key":"10.1016\/j.jdin.2022.02.006_bib34","doi-asserted-by":"crossref","first-page":"e251","DOI":"10.1097\/INF.0000000000003115","article-title":"Hair loss as a late complication of multisystem inflammatory syndrome in children","volume":"40","author":"Savas Sen","year":"2021","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.jdin.2022.02.006_bib35","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14295","article-title":"Alopecia areata in a patient with SARS-CoV-2 infection","volume":"33","author":"Sgubbi","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jdin.2022.02.006_bib36","first-page":"1","article-title":"COVID-19 related anagen effluvium","author":"Shanshal","year":"2020","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jdin.2022.02.006_bib37","first-page":"1","article-title":"COVID-19 infection is a major cause of acute telogen effluvium","author":"Sharquie","year":"2021","journal-title":"Ir J Med Sci"},{"issue":"6","key":"10.1016\/j.jdin.2022.02.006_bib38","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1136\/annrheumdis-2020-218246","article-title":"Mild COVID-19 in ANCA-associated vasculitis treated with rituximab","volume":"80","author":"Suarez-Diaz","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jdin.2022.02.006_bib39","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijid.2021.04.088","article-title":"Clinical course of alopecia after COVID-19","volume":"107","author":"Suzuki","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"2","key":"10.1016\/j.jdin.2022.02.006_bib40","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14791","article-title":"The development of dermatologic diseases in patients recovered from COVID-19","volume":"34","author":"Temiz","year":"2021","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jdin.2022.02.006_bib41","doi-asserted-by":"crossref","first-page":"5595016","DOI":"10.1155\/2021\/5595016","article-title":"Patient recovery from COVID-19 infections: follow-up of hair, nail, and cutaneous manifestations","volume":"2021","author":"Thuangtong","year":"2021","journal-title":"Biomed Res Int"},{"issue":"9","key":"10.1016\/j.jdin.2022.02.006_bib42","doi-asserted-by":"crossref","first-page":"e553","DOI":"10.1111\/jdv.17353","article-title":"Androgenetic alopecia in women and men is not related to COVID-19 infection severity: a prospective cohort study of hospitalized COVID-19 patients","volume":"35","author":"Torabi","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.jdin.2022.02.006_bib43","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/ced.14267","article-title":"Skin signs resembling vascular acrosyndromes during the COVID-19 outbreak in Italy","volume":"45","author":"Tosti","year":"2020","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"10.1016\/j.jdin.2022.02.006_bib44","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/exd.14259","article-title":"What can the hair tell us about COVID-19?","volume":"30","author":"Trueb","year":"2021","journal-title":"Exp Dermatol"},{"issue":"2","key":"10.1016\/j.jdin.2022.02.006_bib45","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jaad.2020.05.079","article-title":"Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: the \u201cGabrin sign\u201d","volume":"83","author":"Wambier","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.jdin.2022.02.006_bib46","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/ijd.15544","article-title":"COVID-19 dermatological manifestations: results from the Mexican Academy of Dermatology COVID-19 registry","volume":"60","author":"Welsh","year":"2021","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.jdin.2022.02.006_bib47","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cmi.2020.09.023","article-title":"Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study","volume":"27","author":"Xiong","year":"2021","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10.1016\/j.jdin.2022.02.006_bib48","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/j.1365-2133.2003.05565.x","article-title":"Androgenetic alopecia in men aged 40-69 years: prevalence and risk factors","volume":"149","author":"Severi","year":"2003","journal-title":"Br J Dermatol"},{"issue":"18","key":"10.1016\/j.jdin.2022.02.006_bib49","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jdin.2022.02.006_bib50","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1749-6632.1951.tb31971.x","article-title":"Patterned loss of hair in man; types and incidence","volume":"53","author":"Hamilton","year":"1951","journal-title":"Ann NY Acad Sci"},{"issue":"2","key":"10.1016\/j.jdin.2022.02.006_bib51","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1046\/j.1365-2133.2001.04018.x","article-title":"Hair density, hair diameter and the prevalence of female pattern hair loss","volume":"144","author":"Birch","year":"2001","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.jdin.2022.02.006_bib52","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.3390\/cancers12082325","article-title":"Sex hormones and hormone therapy during COVID-19 pandemic: implications for patients with cancer","volume":"12","author":"Cattrini","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.jdin.2022.02.006_bib53","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a\u00a0clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.jdin.2022.02.006_bib54","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1111\/jdv.16953","article-title":"Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men","volume":"35","author":"Goren","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"10.1016\/j.jdin.2022.02.006_bib55","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.annonc.2020.04.479","article-title":"Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N\u00a0= 4532)","volume":"31","author":"Montopoli","year":"2020","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.jdin.2022.02.006_bib56","article-title":"Proxalutamide significantly accelerates viral clearance and reduces time to clinical remission in patients with mild to moderate COVID-19: results from a randomized, double-blinded, placebo-controlled trial","volume":"13","author":"Cadegiani","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.jdin.2022.02.006_bib57","doi-asserted-by":"crossref","first-page":"668698","DOI":"10.3389\/fmed.2021.668698","article-title":"Proxalutamide reduces the rate of hospitalization for COVID-19 male outpatients: a randomized double-blinded placebo-controlled trial","volume":"8","author":"McCoy","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"9","key":"10.1016\/j.jdin.2022.02.006_bib58","first-page":"WE01","article-title":"Telogen effluvium: a review","volume":"9","author":"Malkud","year":"2015","journal-title":"J Clin Diagn Res"},{"issue":"suppl 1","key":"10.1016\/j.jdin.2022.02.006_bib59","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.1365-4362.1999.00003.x","article-title":"Diffuse hair loss","volume":"38","author":"Sinclair","year":"1999","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.jdin.2022.02.006_bib60","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","article-title":"The pathogenesis and treatment of the \u2018cytokine storm\u2019 in COVID-19","volume":"80","author":"Ye","year":"2020","journal-title":"J Infect"},{"issue":"10223","key":"10.1016\/j.jdin.2022.02.006_bib61","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jdin.2022.02.006_bib62","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2133.2005.06453.x","article-title":"Interferon-gamma is a potent inducer of catagen-like changes in cultured human anagen hair follicles","volume":"152","author":"Ito","year":"2005","journal-title":"Br J Dermatol"},{"issue":"12","key":"10.1016\/j.jdin.2022.02.006_bib63","doi-asserted-by":"crossref","first-page":"e754","DOI":"10.1016\/S2665-9913(20)30343-X","article-title":"Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study","volume":"2","author":"Webb","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.jdin.2022.02.006_bib64","series-title":"Telogen Effluvium","author":"Hughes","year":"2021"},{"key":"10.1016\/j.jdin.2022.02.006_bib65","doi-asserted-by":"crossref","first-page":"758069","DOI":"10.3389\/fmed.2021.758069","article-title":"Lack of evidence of COVID-19 being a risk factor of alopecia areata: results of a national cohort study in South Korea","volume":"8","author":"Kim","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.jdin.2022.02.006_bib66","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s40257-017-0312-y","article-title":"Evaluation of the relationship between alopecia areata and viral antigen exposure","volume":"19","author":"Richardson","year":"2018","journal-title":"Am J Clin Dermatol"},{"issue":"5","key":"10.1016\/j.jdin.2022.02.006_bib67","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/bjd.16808","article-title":"Alopecia areata: a review of disease pathogenesis","volume":"179","author":"Rajabi","year":"2018","journal-title":"Br J Dermatol"}],"container-title":["JAAD International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666328722000220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666328722000220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T21:00:44Z","timestamp":1762981244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666328722000220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":67,"alternative-id":["S2666328722000220"],"URL":"https:\/\/doi.org\/10.1016\/j.jdin.2022.02.006","relation":{},"ISSN":["2666-3287"],"issn-type":[{"value":"2666-3287","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alopecia in patients with COVID-19: A\u00a0systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"JAAD International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdin.2022.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}